-
Mashup Score: 8Home - ClinicalTrials.gov - 2 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine. IMPORTANT: Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Search for
Source: clinicaltrials.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 66Virtual Grand Rounds in Radiation Oncology - 2 month(s) ago
Latest Science – Top Speakers – Interactive Format We proudly present the newly established “Virtual Grand Rounds in Radiation Oncology”.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 66Virtual Grand Rounds in Radiation Oncology - 3 month(s) ago
Latest Science – Top Speakers – Interactive Format We proudly present the newly established “Virtual Grand Rounds in Radiation Oncology”.
Source: www.usz.chCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 8Home - ClinicalTrials.gov - 3 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information. ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. ClinicalTrials.gov is a resource provided by the U.S. National Library of Medicine. IMPORTANT: Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Search for
Source: clinicaltrials.govCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 24
Endocrine therapy was associated with a greater reduction in HRQOL, as measured by GHS, compared with radiotherapy at 24 months. While these interim results suggest radiotherapy might better preserve HRQOL in older women with low-risk early breast cancer, further data on disease control outcomes and final patient accrual are needed to draw definitive conclusions.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 24
Endocrine therapy was associated with a greater reduction in HRQOL, as measured by GHS, compared with radiotherapy at 24 months. While these interim results suggest radiotherapy might better preserve HRQOL in older women with low-risk early breast cancer, further data on disease control outcomes and final patient accrual are needed to draw definitive conclusions.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 26कनाडा में भारतीय छात्रों के खिलाफ बढ़ती हिंसा पर अभाविप ने व्यक्त की गहरी चिंता | अखिल भारतीय विद्यार्थी परिषद - 3 month(s) ago
दि.
Source: abvp.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 24
Endocrine therapy was associated with a greater reduction in HRQOL, as measured by GHS, compared with radiotherapy at 24 months. While these interim results suggest radiotherapy might better preserve HRQOL in older women with low-risk early breast cancer, further data on disease control outcomes and final patient accrual are needed to draw definitive conclusions.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 5Podcast: What Challenges Will Oncologists Face in 2025? - 3 month(s) ago
Dr. Nathan Pennell and Dr. John Sweetenham discuss the evolving landscape of oncology in 2025 and the challenges oncologists will be facing, including the impact of Medicare drug price negotiations, ongoing drug shortages, and the promising role of AI and telehealth in improving patient outcomes and access to clinical trials.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 3SAMBAI - 3 month(s) ago
Meet SAMBAI, whose challenge is to understand the mechanisms through which genetics, biology, and social determinants affect cancer risk and outcomes in diverse populations, to motivate interventions to reduce cancer inequities.
Source: www.cancergrandchallenges.orgCategories: General Medicine News, Oncologists2Tweet
RT @jillfeldman4: The most experienced patients & advocates struggle to search for #clinicaltrial, even on https://t.co/ZNn0IP9nxh. A user-…